Published in Clin Exp Rheumatol on August 30, 2010
Screening, diagnosis and treatment of osteoporosis: a brief review. Clin Cases Miner Bone Metab (2014) 0.99
Male Osteoporosis in the Elderly. Int J Endocrinol (2015) 0.81
Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis. J Endocrinol Invest (2016) 0.77
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Coeliac disease in the year 2000: exploring the iceberg. Lancet (1994) 6.05
Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med (1999) 5.65
Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (1992) 5.18
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int (2000) 4.85
Metformin in non-alcoholic steatohepatitis. Lancet (2001) 3.63
Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int (2006) 2.79
Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet (1997) 2.78
Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis (2013) 2.77
Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology (2001) 2.74
Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol (1998) 2.70
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol (2000) 2.47
Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood (2000) 2.46
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int (2007) 2.31
Kidney graft survival in rats without immunosuppressants after intrathymic glomerular transplantation. Lancet (1991) 2.26
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
Clonal rat parathyroid cell line expresses a parathyroid hormone-related peptide but not parathyroid hormone itself. Biochem Biophys Res Commun (1989) 2.15
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest (2001) 2.10
Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women. J Bone Miner Res (1999) 2.05
Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol (2000) 2.01
Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol (1994) 2.01
R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int (2007) 2.01
Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med (1996) 1.99
Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest (1996) 1.83
Validation of a functional method for the estimation of hip joint centre location. J Biomech (1999) 1.82
Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporos Int (2005) 1.80
Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology (2000) 1.80
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab (2013) 1.77
Strontium absorption and excretion in normocalciuric subjects: relation to calcium metabolism. Clin Chem (1998) 1.76
Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas. J Pathol (1998) 1.72
Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest (1995) 1.68
Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab (1996) 1.68
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporos Int (2010) 1.68
Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int (2003) 1.65
Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol (2012) 1.65
Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med (1989) 1.64
Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia (2005) 1.63
Long-term results of spine surgery in Duchenne muscular dystrophy. Neuromuscul Disord (1996) 1.61
Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int (2001) 1.58
Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med (2005) 1.58
Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer (1996) 1.57
Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab (2002) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Indwelling ureteral stents and sexual health: a prospective, multivariate analysis. J Urol (2007) 1.55
Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J Bone Miner Res (1993) 1.55
Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol (2001) 1.55
Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone (2011) 1.55
Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int (2006) 1.54
Rear-foot, mid-foot and fore-foot motion during the stance phase of gait. Gait Posture (2006) 1.53
Validity of T2 mapping in characterization of the regeneration tissue by bone marrow derived cell transplantation in osteochondral lesions of the ankle. Eur J Radiol (2010) 1.53
Elective segmental ureterectomy for transitional cell carcinoma of the ureter: long-term follow-up in a series of 73 patients. BJU Int (2012) 1.51
Treatment of an aneurysm of the coeliac axis by transluminal steel wire occlusion. Eur J Vasc Endovasc Surg (1997) 1.48
Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med (1974) 1.47
Ultrasonography in ulnar neuropathy at the elbow: relationships to clinical and electrophysiological findings. Neurophysiol Clin (2008) 1.46
Alignments and clinical results in conventional and navigated total knee arthroplasty. Clin Orthop Relat Res (2007) 1.46
Improving adherence to and persistence with oral therapy of osteoporosis. Osteoporos Int (2015) 1.46
CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity. J Neurol (1989) 1.46
Noninvasive management of obstructing ureteral stones using electromagnetic extracorporeal shock wave lithotripsy. Surg Endosc (2008) 1.46
Physiological carotid body denervation during aging. Adv Exp Med Biol (2009) 1.45
Osteocalcin levels in diabetic subjects. Calcif Tissue Int (1989) 1.45
Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol (2005) 1.44
Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone. J Endocrinol Invest (2012) 1.43
The effect of surface material and roughness on bone screw stability. J Orthop Trauma (1999) 1.43
Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1999) 1.43
Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link? J Endocrinol Invest (2015) 1.43
The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood (1998) 1.42
Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J (2001) 1.42
Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int (2001) 1.39
The hyperspectral irradiometer, a new instrument for long-term and unattended field spectroscopy measurements. Rev Sci Instrum (2011) 1.38
Use of an internal standard to measure pyridinoline and deoxypyridinoline in urine. Clin Chem (1994) 1.38
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2005) 1.37
Hip fractures in Italy: 2000-2005 extension study. Osteoporos Int (2009) 1.36
Two functions encoded by adenovirus early region 1A are responsible for the activation and repression of the DNA-binding protein gene. EMBO J (1985) 1.35
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int (2007) 1.33
Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol (2001) 1.31
Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens (2001) 1.30
Bone microarchitecture as an important determinant of bone strength. J Endocrinol Invest (2004) 1.29
Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int (2003) 1.29
The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology (1983) 1.29
Gait abnormalities in minimally impaired multiple sclerosis patients. Mult Scler (1999) 1.29
Antidepressant medications and osteoporosis. Bone (2012) 1.28